05/19/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 5/19/2020. This 20-page document provides guidance for European Union/European Economic Area (EU/EEA) Member States planning to implement COVID-19 monitoring systems at long-term care facilities, and describes the surveillance objectives. Collection of individual case data within facilities for local use, as well as facility-based data to be shared with local and national authorities, will provide the opportunity for early intervention. (PDF)
05/18/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/18/2020. This web page provides resources for state, tribal, local, and territorial health departments on staffing the public health workforce to coordinate the response to the COVID-19 pandemic and reopening state, tribal, local, and territorial programs. Charts show CDC field team deployments and quarantine station deployments by date, and resources from other organizations are provided. (Text)
05/18/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/18/2020. The purpose of this eight-page document is to provide an overview of public health and social measures for COVID-19, and to propose strategies to limit any possible harm resulting from these interventions. The document is intended to inform national and local health authorities and other decision-makers at all levels. (PDF)
05/15/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/15/2020. This seven-page letter details the Emergency Use Authorization for the Everlywell COVID-19 Test Home Collection Kit, which is intended to facilitate self-collection of nasal swab specimens at home by individuals when determined by a healthcare provider to be appropriate based on results of a COVID-19 questionnaire. (PDF)
05/15/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Fulgent COVID-19 by RT-PCR Test, which received an Emergency Use Authorization from the Food and Drug Administration on May 15, 2020. The Fulgent COVID-19 by RT-PCR Test is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 infection by their healthcare provider or self-collected using a home collection kit specified in the test’s instructions for use. (PDF)
05/15/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Assurance SARS-CoV-2 Panel, which received an Emergency Use Authorization from the Food and Drug Administration on May 15, 2020. The Assurance SARS-CoV-2 Panel is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 infection by their healthcare provider or self-collected using a home collection kit specified in the test’s instructions for use. (PDF)
05/15/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for the Western Pacific. Published: 5/15/2020. This 31-page document discusses how countries and areas in the Western Pacific Region have implemented strict non-pharmaceutical interventions (NPIs) against novel coronavirus disease (COVID-19), aiming to interrupt or reduce transmission. Some of these measures have significant socioeconomic costs and may negatively impact the physical and emotional well-being of populations. The document proposes guiding principles and five steps for countries to implement an NPI strategy that balances epidemiological benefit and socioeconomic costs. (PDF)
05/13/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 5/13/2020. This web page summarizes the expected performance of the COVID-19/SARS-CoV-2 serology tests the Food and Drug Administration (FDA) has authorized based on the information FDA reviewed when deciding whether or not to grant these tests an Emergency Use Authorization. It also provides a calculator that will allow users to see the estimated performance of a single test or two independent tests based on their performance characteristics and the estimated prevalence of SARS-CoV-2 antibodies in the target population. (Text)
05/12/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/12/2020. Infection prevention strategies to prevent the spread of COVID-19 are especially challenging to implement in dedicated memory care units where numerous residents with cognitive impairment reside together. This guidance provides considerations for memory care units, including when residents in a memory care unit are suspected or confirmed to have COVID-19. (Text)
05/10/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 5/10/2020. This five-page document provides an overview of surveillance strategies that Member States should consider as part of comprehensive national surveillance for COVID-19. It emphasizes the need to adapt and reinforce existing national systems where appropriate and to scale up surveillance capacities as needed. (PDF)
05/08/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/8/2020. This 13-page tool was developed to help nursing homes prepare for and respond to COVID-19. It should be used as one tool to develop a comprehensive COVID-19 response plan. It may also contain content relevant for assisted living facilities. (PDF)
05/06/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, National Center for Health Statistics (CDC NCHS). Published: 5/6/2020. This web page provides new resources to help monitor and report COVID-19 deaths, including the latest provisional death counts, guidance for filling out death certificates related to COVID-19, and other important alerts and information. (Text)
03/30/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for the Western Pacific. Published: 3/30/2020. This four-page document provides interim guidance on environmental cleaning and disinfection when a COVID-19 case is suspected or confirmed in non-health-care settings, such as hotels and other public places. Disinfectants that are active against enveloped viruses such as COVID-19 virus should be used. (PDF)
03/23/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/23/2020. Data collected using the investigation protocol in this 48-page document will be critical to refine recommendations for case definitions and surveillance; characterize key epidemiological features of COVID-19; help understand spread, severity, spectrum of disease, and impact on the community; and inform guidance for application of countermeasures such as case isolation and contact tracing. It will investigate health workers in a health care setting in which a patient with a laboratory-confirmed COVID-19 infection is receiving care. (PDF)
03/23/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/23/2020. Data collected using the investigation protocol in this 52-page document will be critical to refine recommendations for case definitions and surveillance; characterize key epidemiological features of COVID-19; help understand spread, severity, spectrum of disease, and impact on the community; and inform guidance for application of countermeasures such as case isolation and contact tracing. It will investigate all household contacts of confirmed cases of COVID-19. (PDF)
.png)
No hay comentarios:
Publicar un comentario